Literature DB >> 29886378

Exploring weight control as motivation for illicit stimulant use.

Amanda B Bruening1, Marisol Perez2, Tara K Ohrt1.   

Abstract

OBJECTIVE: Research has highlighted a growing trend among young, adult women to initiate drug use for weight loss. With known suppressive effects on appetite, illicit stimulants (i.e., cocaine, amphetamine, methamphetamine, and ecstasy) may be particularly attractive to college women, who are at elevated risk for increased body dissatisfaction and experimenting with extreme weight loss techniques. The current study examines the association between risk factors and symptomatology of eating disorders and illicit stimulant use (ISU).
METHODS: A preliminary study was conducted on a nonclinical sample of 131 drug-using, college women (16- to 24-years old). Participants reported internalization of the thin ideal, body dissatisfaction, disordered eating behavior, and current drug use as well as corresponding weight-related motivation.
RESULTS: There were 15.3% of women who reported drug use for weight-control purposes. Results showed women who reported drug use for weight control predominantly used illicit stimulants (70%), such as cocaine, amphetamine, methamphetamine, and ecstasy. Moreover, the odds of ISU were increased among women who engaged in laxative misuse.
CONCLUSIONS: These results suggest that a desire for weight control may be associated with ISU among college women. Women engaging in more extreme weight loss behaviors are at high risk for initiating and maintaining ISU for weight-related reasons.
Copyright © 2018. Published by Elsevier Ltd.

Entities:  

Keywords:  Appetite suppression; Compensatory behaviors; Eating disorders; Illicit stimulant use; Weight control

Mesh:

Substances:

Year:  2018        PMID: 29886378     DOI: 10.1016/j.eatbeh.2018.06.002

Source DB:  PubMed          Journal:  Eat Behav        ISSN: 1471-0153


  7 in total

1.  Methamphetamine use and disordered eating: a case study of an understudied phenomenon.

Authors:  Christina J Duval; Ane A Balkchyan; Ani Sarkisyan; Eric R Pedersen; Jason M Nagata; Talene Keshishian; Stuart B Murray
Journal:  Eat Weight Disord       Date:  2022-02-24       Impact factor: 3.008

2.  Leptin Protects Against the Development and Expression of Cocaine Addiction-Like Behavior in Heterogeneous Stock Rats.

Authors:  Lieselot L G Carrette; Cristina Corral; Brent Boomhower; Molly Brennan; Caitlin Crook; Clara Ortez; Kokila Shankar; Sierra Simpson; Lisa Maturin; Leah C Solberg Woods; Abraham A Palmer; Giordano de Guglielmo; Olivier George
Journal:  Front Behav Neurosci       Date:  2022-03-03       Impact factor: 3.558

3.  Infodemiology on diet and weight loss behavior before and during COVID-19 pandemic in Indonesia: Implication for public health promotion.

Authors:  Ira Dewi Ramadhani; Leny Latifah; Andjar Prasetyo; Marizka Khairunnisa; Yurika Fauzia Wardhani; Diah Yunitawati; Mochammad Fahlevi
Journal:  Front Nutr       Date:  2022-09-28

4.  Prevalence and demographic, substance use, and mental health correlates of fasting among U.S. college students.

Authors:  Kyle T Ganson; Rachel F Rodgers; Stuart B Murray; Jason M Nagata
Journal:  J Eat Disord       Date:  2021-07-21

5.  Involvement of dopamine D3 receptor and dopamine transporter in methamphetamine-induced behavioral sensitization in tree shrews.

Authors:  Jian Huang; Genmeng Yang; Zhen Li; Chi-Kwan Leung; Wenguang Wang; Yuanyuan Li; Liu Liu; Baoyu Shen; Cuihua He; Yongwang He; Xiaofeng Zeng; Juan Li
Journal:  Brain Behav       Date:  2020-01-14       Impact factor: 2.708

Review 6.  Separating the Signal from the Noise: How Psychiatric Diagnoses Can Help Discern Food Addiction from Dietary Restraint.

Authors:  David Wiss; Timothy Brewerton
Journal:  Nutrients       Date:  2020-09-25       Impact factor: 5.717

7.  Using Illicit Drugs to Lose Weight among Recovering Female Drug Users in China: An Exploratory Qualitative Study.

Authors:  Liu Liu; Xiaotao Wang; Yang Xie; Wing-Hong Chui
Journal:  Int J Environ Res Public Health       Date:  2022-02-24       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.